Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Chinese Adults With Moderate to Severe Active Crohn's Disease
CTR20212531Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ustekinumab in Crohn's disease, sponsored by Janssen Pharmaceutical. Started Nov 2021; status: completed.
02
Drugs
ustekinumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20212531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212531.